Miyaji EN - Search Results

1

Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil.

Ho PL, Miyaji EN, Oliveira ML, Dias Wde O, Kubrusly FS, Tanizaki MM, Martins EA, Raw I. Ho PL, et al. Among authors: miyaji en. PLoS Negl Trop Dis. 2011 Nov;5(11):e1300. doi: 10.1371/journal.pntd.0001300. Epub 2011 Nov 29. PLoS Negl Trop Dis. 2011. PMID: 22140586 Free PMC article. Review. No abstract available.

2

Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice.

Nascimento IP, Dias WO, Mazzantini RP, Miyaji EN, Gamberini M, Quintilio W, Gebara VC, Cardoso DF, Ho PL, Raw I, Winter N, Gicquel B, Rappuoli R, Leite LC. Nascimento IP, et al. Among authors: miyaji en. Infect Immun. 2000 Sep;68(9):4877-83. doi: 10.1128/IAI.68.9.4877-4883.2000. Infect Immun. 2000. PMID: 10948100 Free PMC article.

3

Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin.

Miyaji EN, Mazzantini RP, Dias WO, Nascimento AL, Marcovistz R, Matos DS, Raw I, Winter N, Gicquel B, Rappuoli R, Leite LC. Miyaji EN, et al. Infect Immun. 2001 Feb;69(2):869-74. doi: 10.1128/IAI.69.2.869-874.2001. Infect Immun. 2001. PMID: 11159980 Free PMC article.

4

Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses.

Miyaji EN, Dias WO, Tanizaki MM, Leite LC. Miyaji EN, et al. FEMS Immunol Med Microbiol. 2003 Jun 10;37(1):53-7. doi: 10.1016/S0928-8244(03)00108-1. FEMS Immunol Med Microbiol. 2003. PMID: 12770760 Free article.

5

Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C.

Mazzantini RP, Miyaji EN, Dias WO, Sakauchi D, Nascimento AL, Raw I, Winter N, Gicquel B, Rappuoli R, Leite LC. Mazzantini RP, et al. Among authors: miyaji en. Vaccine. 2004 Jan 26;22(5-6):740-6. doi: 10.1016/j.vaccine.2003.08.017. Vaccine. 2004. PMID: 14741167

6

Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice.

Arêas AP, Oliveira ML, Miyaji EN, Leite LC, Aires KA, Dias WO, Ho PL. Arêas AP, et al. Among authors: miyaji en. Biochem Biophys Res Commun. 2004 Aug 13;321(1):192-6. doi: 10.1016/j.bbrc.2004.06.118. Biochem Biophys Res Commun. 2004. PMID: 15358234

7

Intradermal immunization of mice with cholera toxin B-pneumococcal surface protein A fusion protein is protective against intraperitoneal challenge with Streptococcus pneumoniae.

Arêas AP, Oliveira ML, Miyaji EN, Leite LC, Ho PL. Arêas AP, et al. Among authors: miyaji en. Infect Immun. 2005 Jun;73(6):3810-3. doi: 10.1128/IAI.73.6.3810-3813.2005. Infect Immun. 2005. PMID: 15908419 Free PMC article. No abstract available.

8

DNA vaccines expressing pneumococcal surface protein A (PspA) elicit protection levels comparable to recombinant protein.

Ferreira DM, Miyaji EN, Oliveira MLS, Darrieux M, Arêas APM, Ho PL, Leite LCC. Ferreira DM, et al. Among authors: miyaji en. J Med Microbiol. 2006 Apr;55(Pt 4):375-378. doi: 10.1099/jmm.0.46217-0. J Med Microbiol. 2006. PMID: 16533983

9

Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.

Oliveira ML, Arêas AP, Campos IB, Monedero V, Perez-Martínez G, Miyaji EN, Leite LC, Aires KA, Lee Ho P. Oliveira ML, et al. Among authors: miyaji en. Microbes Infect. 2006 Apr;8(4):1016-24. doi: 10.1016/j.micinf.2005.10.020. Epub 2006 Jan 18. Microbes Infect. 2006. PMID: 16549380 Free PMC article.

10

Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.

Pimenta FC, Miyaji EN, Arêas AP, Oliveira ML, de Andrade AL, Ho PL, Hollingshead SK, Leite LC. Pimenta FC, et al. Among authors: miyaji en. Infect Immun. 2006 Aug;74(8):4939-44. doi: 10.1128/IAI.00134-06. Infect Immun. 2006. PMID: 16861686 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page